To get the best possible experience using our website we recommend that you upgrade to another web browser. Outdated browsers don't follow the latest web standards, are full of bugs, don't offer the new browser features and may have security issues and malware. These browsers are normally no longer supported.
Please make use of one of the following links to upgrade you browser and website surfing experience. They are free to upgrade and you will have the advantage of having the new browser keep its self up to date as well as the latest features.
Breast cancer affects as many as one in eight women during their lifetime and 1 in 10 women globally die of the disease. In the families that it affects it causes immeasurable anxiety, suffering and loss. In many of the regions of the world, it is the most frequently occurring malignant disease in women, placing an enormous drain on healthcare resources, both directly and indirectly. The burden of breast cancer worldwide in both developed and developing countries is increasing and evidence suggests that unless action is taken it will continue to grow for the foreseeable future.
Effective countermeasures directed towards primary prevention, early diagnosis and therapy need to be identified and implemented to prevent the disease reaching epidemic proportions. This course will provide the professional with the latest cutting-edge information with regards breast cancer, equipping them with knowledge to diagnose breast cancer early, thereby reducing the mortality rate, as well as the cost of treatment.
AstraZeneca Pharmaceuticals (Pty) Ltd has introduced a access initiative called Phakamisa to impact on the burden Breast Cancer has on the public system. Phakamisa navigates diagnosed Breast Cancer patients in the public sector by means of support of volunteers, educates HCP's managing Breast Cancer and ensures that more patients have access to the right drugs on state tender.
All professionals that are involved in Primary Health Care in the South African public sector.
Distance education through a comprehensive self-study guide developed by experts in the field supported by 1 day interactive contact session.
In order to ensure compliance of the self-study requirements of the course the participants will have to successfully complete a multiple-choice questionnaire. Participants need to achieve a score of 70% on the assessment questionnaire in order to pass this aspect of the course.
The course is accredited for 20 CEU's according to the HPCSA CPD Guidelines for health care professionals. 6 CEU's for workshop attendance, 14 CEU's for the assessment.
After working through this module you should:
Full sponsorship funded by AstraZeneca, are available to participants who meet specific criteria. Sponsorship covers all tuition costs, including study material and workshops costs.
Note: Candidate must however cover their own travel and accommodation costs.
|4 Aug 2012||KZN||Durban-North Beach|
|11 Aug 2012||Gauteng||Midrand Protea Hotel|
|13 Oct 2012||Cape Town||Strand Towers|
|20 Oct 2012||Bloemfontein||Anta Bouga Hotel|
|3 Nov 2012||Limpopo||Fusion Bout Hotel|
DANIELLE DANIELS / STACEY DIAS